Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)

NCT04341129 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT04341129
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04341129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)
Lead sponsor
University of Chicago
Phase
Phase 1
Overall status
Completed
Start date
July 13, 2020
Completion date
June 30, 2023
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast diseases, breast fibroadenoma, breast neoplasms